Evidence map›Paper›PMID 32366892›Full record

ArticleCell death & disease2020

Formate induces a metabolic switch in nucleotide and energy metabolism.

Kristell Oizel, Jacqueline Tait-Mulder, Jorge Fernandez-de-Cossio-Diaz, Matthias Pietzke, Holly Brunton, Sergio Lilla, Sandeep Dhayade, Dimitri Athineos, Giovanny Rodriguez Blanco, David Sumpton and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Acidity induces durable enhancement of TMolecular immunology · 2024
    Article
  17. Flavin-containing monooxygenase (FMO): Beyond xenobiotics.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Kristell Oizel *Cancer Research UK Beatson Institute, Glasgow, UK.
Jacqueline Tait-Mulder *Cancer Research UK Beatson Institute, Glasgow, UK.
Jorge Fernandez-de-Cossio-DiazCenter of Molecular Immunology, Havana, Cuba.
Matthias PietzkeCancer Research UK Beatson Institute, Glasgow, UK.
Holly BruntonCancer Research UK Beatson Institute, Glasgow, UK.
Sergio LillaCancer Research UK Beatson Institute, Glasgow, UK.ORCID http://orcid.org/0000-0003-3142-7640
Sandeep DhayadeCancer Research UK Beatson Institute, Glasgow, UK.
Dimitri AthineosCancer Research UK Beatson Institute, Glasgow, UK.ORCID http://orcid.org/0000-0001-5298-7941
Giovanny Rodriguez BlancoCancer Research UK Beatson Institute, Glasgow, UK.ORCID http://orcid.org/0000-0002-7154-7244
David SumptonCancer Research UK Beatson Institute, Glasgow, UK.ORCID http://orcid.org/0000-0002-9004-4079
Gillian M MackayCancer Research UK Beatson Institute, Glasgow, UK.
Karen BlythCancer Research UK Beatson Institute, Glasgow, UK.
Sara R ZanivanCancer Research UK Beatson Institute, Glasgow, UK.ORCID http://orcid.org/0000-0002-9880-9099
Johannes MeiserDepartment of Oncology, Luxembourg Institute of Health, L-1526, Luxembourg, Luxembourg.
Alexei VazquezCancer Research UK Beatson Institute, Glasgow, UK. alexei.vazquezvazquez@glasgow.ac.uk.ORCID http://orcid.org/0000-0003-2764-3244
Cancer Research UK Scotland Institute · GBCenter of Molecular Immunology (Cuba) · CULuxembourg Institute of Health · LU

Funding

Cancer Research UK 21140Cancer Research UK 29799Cancer Research UK 29800Cancer Research UK C596/A17196Cancer Research UK C596/A18076Cancer Research UK C596/A21140
6 · The paper itself

Abstract

Formate is a precursor for the de novo synthesis of purine and deoxythymidine nucleotides. Formate also interacts with energy metabolism by promoting the synthesis of adenine nucleotides. Here we use theoretical modelling together with metabolomics analysis to investigate the link between formate, nucleotide and energy metabolism. We uncover that endogenous or exogenous formate induces a metabolic switch from low to high adenine nucleotide levels, increasing the rate of glycolysis and repressing the AMPK activity. Formate also induces an increase in the pyrimidine precursor orotate and the urea cycle intermediate argininosuccinate, in agreement with the ATP-dependent activities of carbamoyl-phosphate and argininosuccinate synthetase. In vivo data for mouse and human cancers confirms the association between increased formate production, nucleotide and energy metabolism. Finally, the in vitro observations are recapitulated in mice following and intraperitoneal injection of formate. We conclude that formate is a potent regulator of purine, pyrimidine and energy metabolism.

Indexed as

Adenosine TriphosphateAdenylate KinaseAminoimidazole CarboxamideAnimalsCell Line, TumorColorectal NeoplasmsDisease Models, AnimalEnergy MetabolismFemaleFormatesHumansMice, Inbred C57BLModels, BiologicalModels, GeneticNucleotidesOrotic AcidAdenosine TriphosphateAdenylate KinaseAICA ribonucleotideAminoimidazole CarboxamideFormatesformic acidNucleotidesOrotic AcidpyrimidinePyrimidinesRibonucleotides

Identifiers

PMID32366892
PMCPMC7198490
OpenAlexW3022054920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.